Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common type of liver cancer, accounting for approximately 85–90% of all cases of liver cancer worldwide. The five-year tumor recurrence rate has been estimated to be 70% among patients who present with resectable disease and undergo resectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamseddine, Shadi, LaPelusa, Michael, Kaseb, Ahmed Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340217/
https://www.ncbi.nlm.nih.gov/pubmed/37444618
http://dx.doi.org/10.3390/cancers15133508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340217/
https://www.ncbi.nlm.nih.gov/pubmed/37444618
http://dx.doi.org/10.3390/cancers15133508

Ejemplares similares